D. Geraghty

发表

Predicting multiallelic genes using unphased and flanking single nucleotide polymorphisms

Bo Zhang, Lue Ping Zhao, Hongwei Wang, 2011, Genetic epidemiology.

Complete sequence and gene map of a human major histocompatibility complex

Gen Tamiya, Simon A. Forbes, Stephan Beck, 1999 .

Nomenclature for factors of the HLA system, 2010

W. Bodmer, P. Parham, J. Trowsdale, 2010, Tissue antigens.

An Object‐Oriented Regression for Building Disease Predictive Models with Multiallelic HLA Genes

L. Zhao, H. Bolouri, Å. Lernmark, 2016, Genetic epidemiology.

Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection

John Bui, Quyen Vu, Lue Ping Zhao, 2006, Journal of Virology.

Effect of Fc Receptor Genetic Diversity on HIV-1 Disease Pathogenesis

J. Fellay, D. Geraghty, Rasmi Thomas, 2019, Front. Immunol..

Revealing complete complex KIR haplotypes phased by long-read sequencing technology

S. Ranade, R. Kuang, K. Eng, 2017, Genes and Immunity.

MICA allele typing of HLA-B27 positive Japanese patients with seronegative spondylarthropathies and healthy individuals: differential linkage disequilibrium with HLA-B27 subtypes.

K. Tokunaga, N. Tsuchiya, D. Geraghty, 1998, Arthritis and rheumatism.

Mapping and characterization of non-HLA multigene assemblages in the human MHC class I region.

C. Venditti, D. Geraghty, M. Chorney, 1994, Genomics.

Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.

D. Geraghty, E. Sheiner, H. Hyodo, 2007, American journal of obstetrics and gynecology.

HLA‐E‐bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA‐G‐derived nonamer

M. Llano, F. Navarro, M. López-Botet, 1998, European journal of immunology.

High-throughput killer cell immunoglobulin-like receptor genotyping by MALDI-TOF mass spectrometry with discovery of novel alleles

P. Parham, R. Nichols, D. Geraghty, 2007, Immunogenetics.

The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells

C. Retière, D. Geraghty, J. Bruneau, 2019, Journal of Virology.

Dependence of Peptide Binding by MHC Class I Molecules on Their Interaction with TAP

A. G. Grandea, D. Geraghty, R. Athwal, 1995, Science.

from Tapasin and Completely Independent Independent Monocyte Cell Lines Is Partially HLA-F Surface Expression on B Cell and

D. Geraghty, N. Lee, 2017 .

HLA-F Surface Expression on B Cell and Monocyte Cell Lines Is Partially Independent from Tapasin and Completely Independent from TAP1

D. Geraghty, N. Lee, 2003, The Journal of Immunology.

The primary structure of a plant storage protein: zein.

J. Messing, D. Geraghty, I. Rubenstein, 1981, Nucleic acids research.

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells

M. Colonna, M. Llano, F. Navarro, 1999, European journal of immunology.

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial

Lindsay N. Carpp, Allan C. deCamp, S. Hammer, 2019, Journal of Virology.

MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype

Takashi Shiina, Hidetoshi Inoko, H. Inoko, 1999, Immunogenetics.

MIC-A polymorphism and a MIC-A-MIC-B null haplotype with ~ 100-kb deletion

H. Inoko, T. Shiina, K. Tokunaga, 2000 .

Large-scale comparative mapping of the MHC class I region of predominant haplotypes in Japanese

K. Tadokoro, K. Tokunaga, D. Geraghty, 1997, Immunogenetics.

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120

Lindsay N. Carpp, Allan C. deCamp, Jerome H. Kim, 2017, PloS one.

Cross-Presentation Pathway Cooperate in a MHC-I Antigen HLA-F and MHC-I Open Conformers

E. Warren, C. Yee, D. Geraghty, 2013 .

HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway

E. Warren, S. Riddell, C. Yee, 2013, The Journal of Immunology.

A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment.

H. Orr, B. Koller, D. Geraghty, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Genetic risk factors for sclerotic graft-versus-host disease.

L. Zhao, B. Storer, E. Warren, 2014, Blood.

HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients

A. Goris, D. Geraghty, N. Hellings, 2014, Multiple sclerosis.

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, bioRxiv.

Specific engagement of the CD94/NKG2‐A killer inhibitory receptor by the HLA‐E class Ib molecule induces SHP‐1 phosphatase recruitment to tyrosine‐phosphorylated NKG2‐A: evidence for receptor function in heterologous transfectants

M. Llano, A. Santoni, M. Carretero, 1998, European journal of immunology.

Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes.

H. Orr, J. Strominger, B. Koller, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Different DRB1*03:01‐DQB1*02:01 haplotypes confer different risk for celiac disease

L. P. Zhao, Å. Lernmark, D. Geraghty, 2017, HLA.

HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors

D. Geraghty, J. Goodridge, N. Lee, 2013, The Journal of Immunology.

Building and validating a prediction model for paediatric type 1 diabetes risk using next generation targeted sequencing of class II HLA genes

L. Zhao, H. Bolouri, Å. Lernmark, 2017, Diabetes/metabolism research and reviews.

Homotypic aggregation of human cell lines by HLA class II‐, class Ia‐ and HLA‐G‐specific monoclonal antibodies

J. Ledbetter, D. Geraghty, J. Hansen, 1991, European journal of immunology.

Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells

H. Orr, B. Koller, R. Demars, 1986, Molecular and cellular biology.

High‐resolution genotyping indicates that children with type 1 diabetes and celiac disease share three HLA class II loci in DRB3, DRB4 and DRB5 genes

D. Geraghty, D. Agardh, H. Larsson, 2020, HLA.

HLA‐F is a surface marker on activated lymphocytes

D. Geraghty, N. Lee, A. Ishitani, 2010, European journal of immunology.

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

D. Geraghty, A. Ishitani, 1992, Proceedings of the National Academy of Sciences of the United States of America.

A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.

D. Geraghty, T. Fujii, A. Ishitani, 1994, Journal of immunology.

Cytokine regulation of HLA-G expression in human trophoblast cell lines.

D. Geraghty, J. S. Hunt, Y. Yang, 1995, Journal of reproductive immunology.

Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.

D. Geraghty, J. S. Hunt, Y. Yang, 1996, Journal of immunology.

HLA-F Complex without Peptide Binds to MHC Class I Protein in the Open Conformer Form

D. Geraghty, J. Goodridge, N. Lee, 2010, The Journal of Immunology.

Expression of nonclassical class I molecules by intestinal epithelial cells

D. Geraghty, L. Mayer, T. Spies, 2007, Inflammatory bowel diseases.

HLA-E. A novel HLA class I gene expressed in resting T lymphocytes.

H. Orr, B. Koller, R. Demars, 1988, Journal of immunology.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Immunogenetics.

HLA-E is a major ligand for the natural killer inhibitory receptor CD 94 y NKG 2 A

M. Llano, M. Carretero, F. Navarro, 1998 .

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

G. Ferrara, J. Dausset, R. Fauchet, 2000, Human immunology.

Organization of the human class I major histocompatibility complex genes

H. Orr, B. Koller, R. Demars, 1987, Immunologic research.

The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.

I. Melero, M. Colonna, M. Llano, 1997, Journal of immunology.

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment.

G. Ferrara, M. Maio, D. Geraghty, 2000, Tissue antigens.

HLA‐G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex

D. Geraghty, P. Le Bouteiller, L. Moretta, 1997, European journal of immunology.

Association of HLA-DQ Heterodimer Residues −18β and β57 With Progression From Islet Autoimmunity to Diabetes in the Diabetes Prevention Trial–Type 1

L. Zhao, J. Skyler, D. Geraghty, 2022, Diabetes care.

Examination of four HLA class I pseudogenes. Common events in the evolution of HLA genes and pseudogenes.

B. Koller, D. Geraghty, J. Hansen, 1992, Journal of immunology.

HLA-AR, an inactivated antigen-presenting locus related to HLA-A. Implications for the evolution of the MHC.

P. Parham, H. Orr, B. Koller, 1990, Journal of immunology.

Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G

Eric O Long, D. Geraghty, I. Joosten, 2005, PLoS biology.

Isolation and characterization of yeast artificial chromosome clones linking the HLA-B and HLA-C loci.

P. Taillon-Miller, D. Chaplin, D. Geraghty, 1991, Proceedings of the National Academy of Sciences of the United States of America.

HLA-G1 protein expression is not essential for fetal survival.

C. Ober, D. Geraghty, J. S. Hunt, 1998, Placenta.

Chromosomal organization of the human major histocompatibility complex class I gene family [published erratum appears in J Exp Med 1989 Apr 1;169(4):1517]

H. Orr, S. Rich, B. Koller, 1989, The Journal of experimental medicine.

Chromosomal organization of the human major histocompatibility complex class I gene family [published erratum appears in J Exp Med 1989 Apr 1;169(4):1517]

H. Orr, S. Rich, B. Koller, 1989, The Journal of experimental medicine.

HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1

D. Geraghty, J. Bruneau, N. Bernard, 2019, Journal of Virology.

Application of Statistical Learning to Identify Omicron Mutations in SARS-CoV-2 Viral Genome Sequence Data From Populations in Africa and the United States

L. Zhao, T. Lybrand, D. Geraghty, 2022, JAMA network open.

A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.

J. Mullins, T. Hertz, J. Kublin, 2016, Vaccine.

Structure of the HLA class I region and expression of its resident genes.

D. Geraghty, 1993, Current opinion in immunology.

Expression and regulation of HLA-G in human glioma cell lines.

S. Maier, D. Geraghty, E. Weiss, 1999, Transplantation proceedings.

Transfected human class I gene product adequately assembles minor histocompatibility antigens

D. Geraghty, E. Goulmy, J. Pool, 2004, Immunogenetics.

Structure and expression of a divergent canine class I gene.

D. Geraghty, R. Burnett, 1995, Journal of immunology.

High‐resolution HLA class II sequencing of Swedish multiple sclerosis patients

L. Zhao, D. Geraghty, O. Akel, 2022, International journal of immunogenetics.

Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA-E, F, and G in Maternal-Placental Immune Recognition 1

D. Geraghty, H. Marquardt, K. Hatake, 2003, The Journal of Immunology.

Reprogramming of CTLs into natural killer–like cells in celiac disease

E. Kistner, R. Winchester, G. Bhagat, 2006, The Journal of experimental medicine.

Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA‐G

D. Geraghty, P. Le Bouteiller, A. Blaschitz, 1997, European journal of immunology.

Transfer and Expression of Human Non-A,B,C Class I Genes in Human HLA A,B,C Null Lymphoblastoid Cells

H. Orr, B. Koller, R. Demars, 1989 .

Analysis of HLA-E expression in human tumors

D. Geraghty, F. Garrido, P. Jiménez, 2003, Immunogenetics.

HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1

D. Geraghty, J. Bruneau, B. Lebouché, 2018, The Journal of Immunology.

Broadly neutralizing antibodies target the coronavirus fusion peptide

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Science.

Fetal human leukocyte antigen-C and maternal killer-cell immunoglobulin-like receptors in cases of severe preeclampsia.

D. Geraghty, T. Hviid, R. Hackmon, 2019, Placenta.

Human Leukocyte Antigen HLA-C, HLA-G, HLA-F and HLA-E placental profiles are altered in Early Severe Preeclampsia and Preterm Birth with Chorioamnionitis.

S. Lye, D. Geraghty, L. Myatt, 2022, American journal of obstetrics and gynecology.

Definitive class I human leukocyte antigen expression in gestational placentation: HLA‐F, HLA‐E, HLA‐C, and HLA‐G in extravillous trophoblast invasion on placentation, pregnancy, and parturition

S. Lye, D. Geraghty, C. Dunk, 2017, American journal of reproductive immunology.

HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation.

K. Lim, S. Fisher, Y. Zhou, 1998, Journal of immunology.

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1

R. Strong, D. Geraghty, K. Finton, 2016, PloS one.

Thermodynamics Display Overlapping Affinities and Immunoreceptors and HLA-E Ligands Interactions between NKG 2 x

D. Geraghty, W. Paulsene, Scott Medley, 2005 .

Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy

L. Zhao, T. Lybrand, D. Geraghty, 2022, Scientific Reports.

HLA-G in reproduction: studies on the maternal-fetal interface.

C. Ober, D. Geraghty, J. S. Hunt, 2000, Human immunology.

Cloning and physical mapping of the HLA class I region spanning the HLA-E-to-HLA-F interval by using yeast artificial chromosomes.

P. Taillon-Miller, Benjamin A Lipsky, D. Chaplin, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Genotyping of canine MHC gene DLA‐88 by next‐generation sequencing reveals high frequencies of new allele discovery and gene duplication

D. Geraghty, B. Torok-Storb, M. Harkey, 2022, HLA.

The HLA system in clinical marrow transplantation.

D. Geraghty, J. Hansen, S. Choo, 1990, Hematology/oncology clinics of North America.

The Expression of Human Leukocyte Antigen‐G on Trophoblasts Abolishes the Growth‐Suppressing Effect of Interleukin‐2 towards Them

S. Kōzuma, Y. Taketani, D. Geraghty, 1999, American journal of reproductive immunology.

Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts.

D. Geraghty, J. S. Hunt, M. Fant, 1998, Human immunology.

Are Due to Unusual Glycosylation Cytotrophoblasts and Found in Amniotic Fluid HLA-G Isoforms Produced by Placental

K. Lim, S. Fisher, D. Geraghty, 1998 .

A Soluble Isoform of the Rhesus Monkey Nonclassical MHC Class I Molecule Mamu-AG Is Expressed in the Placenta and the Testis1

D. Geraghty, R. L. Grendell, T. Golos, 2002, The Journal of Immunology.

the Testis Mamu-AG Is Expressed in the Placenta and Nonclassical MHC Class I Molecule A Soluble Isoform of the Rhesus Monkey

D. Geraghty, R. L. Grendell, T. Golos, 2002 .

Variants in nucleocapsid protein and endoRNase are found to associate with severe COVID-19 in a case-control study in Washington State, USA

L. Zhao, T. Lybrand, J. Schiffer, 2021 .

Unique and Interacting Functional Roles for Protein Expression and Peptide Binding Suggest

D. Geraghty, H. Marquardt, K. Hatake, 2003 .

Activating KIR (B Haplotype) in Unrelated Donors Improves Disease-Free Survival after HLA-Matched and Mismatched Allogeneic Transplantation for Acute Myeloid Leukemia: Implications for Donor Selection Using KIR Genotyping.

J. Klein, P. Parham, Jeffrey S. Miller, 2007 .

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report

J. Radich, S. Meshinchi, D. Stirewalt, 2013, Leukemia.

Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

Peter D. Crompton, J. Mascola, J. Yewdell, 2022, Cell Host & Microbe.

Soluble HLA-G circulates in maternal blood during pregnancy.

C. Ober, D. Geraghty, J. S. Hunt, 2000, American journal of obstetrics and gynecology.

CORRELATING DIFFERENTIAL EXPRESSION, PEPTIDE AFFINITIES, CRYSTAL STRUCTURES, AND THERMAL STABILITIES*

R. Strong, M. Holmes, D. Geraghty, 2003 .

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

M. Llano, M. Carretero, F. Navarro, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Human Cytomegalovirus Gene Products US3 and US6 Down-Regulate Trophoblast Class I MHC Molecules1

D. Geraghty, H. Sung, Eunok Kim, 2000, The Journal of Immunology.

Interferons enhance HLA-G mRNA and protein in transfected mouse fibroblasts.

D. Geraghty, J. S. Hunt, Y. Yang, 1999, Journal of reproductive immunology.

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.

J. Bajorath, D. Geraghty, H. Marquardt, 1995, Immunity.

Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element

H. Orr, B. Koller, D. Geraghty, 1990, The Journal of experimental medicine.

Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells.

D E Geraghty, H. Orr, B. Koller, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Chap T Le, Tao Wang, John P Klein, 2010, Blood.

Histocompatibility 1991

D. Geraghty, P. Beatty, E. Mickelson, 1991, Transfusion.

A second lineage of mammalian major histocompatibility complex class I genes.

D. Geraghty, S. Bahram, T. Spies, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes.

L. Zhao, D. Geraghty, J. Hansen, 2006, Genomics.

Genetic divergence of the rhesus macaque major histocompatibility complex.

Gustavo Glusman, Lee Rowen, L. Rowen, 2004, Genome research.

Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden

L. Zhao, Å. Lernmark, D. Geraghty, 2021, Scientific Reports.

Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes

L. Zhao, Å. Lernmark, D. Geraghty, 2020, Diabetes.

Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children

L. Zhao, Å. Lernmark, D. Geraghty, 2020, Diabetes.

Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes

L. Zhao, Å. Lernmark, D. Geraghty, 2019, Diabetes.

The complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism.

D. Geraghty, T. Guillaudeux, M. Janer, 1998, Proceedings of the National Academy of Sciences of the United States of America.

The essential detail: the genetics and genomics of the primate immune response.

D. Geraghty, Q. Vu, C. Pyo, 2013, ILAR journal.

HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes

L. Zhao, D. Geraghty, H. Hyodo, 2006, Immunogenetics.

Genetics of the immune response: identifying immune variation within the MHC and throughout the genome

R. Daza, D. Geraghty, Q. Vu, 2002, Immunological reviews.

Different Patterns of Evolution in the Centromeric and Telomeric Regions of Group A and B Haplotypes of the Human Killer Cell Ig-Like Receptor Locus

Peter Parham, Quyen Vu, Lisbeth A. Guethlein, 2010, PloS one.

Plant Gene Structure

J. Messing, G. Heidecker, D. Geraghty, 1983 .

The human major histocompatibility complex: 42,221 bp of genomic sequence, high-density sequence-tagged site map, evolution, and polymorphism for HLA class I.

D. Geraghty, M. Janer, 1998, Genomics.

Nomenclature for factors of the HLA system, 2004

W R Mayr, D E Geraghty, B Dupont, 2005, Tissue antigens.

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation

Benjamin D. Heavner, B. Storer, D. Geraghty, 2021, Frontiers in Immunology.

Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism.

D. Geraghty, J. Hansen, A. Ishitani, 1992, Human immunology.

survival after unrelated transplantation for acute myelogenous leukemia Donor selection for natural killer cell receptor genes leads to superior

J. Klein, C. Le, P. Parham, 2010 .

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

S G E Marsh, D E Geraghty, P Parham, 2003, Immunogenetics.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Tissue antigens.

An update to HLA Nomenclature, 2010

W R Mayr, D E Geraghty, M Maiers, 2010, Bone Marrow Transplantation.

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection.

N. Frahm, M. McElrath, P. Gilbert, 2013, The Journal of infectious diseases.

T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components

A. Wald, M. Gale, D. Geraghty, 2022, medRxiv.

The killer cell immunoglobulin‐like receptor (KIR) genomic region: gene‐order, haplotypes and allelic polymorphism

K. Hsu, D. Geraghty, Bo Dupont, 2002, Immunological reviews.

Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the step trial.

K. Shianna, D. Goldstein, B. Haynes, 2011, The Journal of infectious diseases.

Maternal and fetal human leukocyte antigen class Ia and II alleles in severe preeclampsia and eclampsia

M. Melbye, D. Geraghty, A. Andersen, 2016, Genes and Immunity.

Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression than HLA Genotype

J. Mullins, M. McElrath, A. Collier, 2010, Journal of Virology.

Nomenclature for factors of the HLA system, 2002.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2002, Human immunology.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors.

Anajane G. Smith, D. Geraghty, J. Hansen, 2014, Human immunology.

An integrated genotyping approach for HLA and other complex genetic systems.

Anajane G. Smith, D. Geraghty, Carly Hennessey, 2015, Human immunology.

Alternative splicing and genetic variation of mhc-e: implications for rhesus cytomegalovirus-based vaccines

E. Tseng, L. Picker, M. Gale, 2022, Communications biology.

A Detailed View of KIR Haplotype Structures and Gene Families as Provided by a New Motif-Based Multiple Sequence Alignment

R. Kuang, M. Maiers, D. Geraghty, 2020, bioRxiv.

Recombinant structures expand and contract inter and intragenic diversification at the KIR locus

M. Carrington, F. Duh, Steven Wolinsky, 2013, BMC Genomics.

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002

Bo Dupont, Derek Middleton, John Trowsdale, 2003, Immunogenetics.

HLA-E Allelic Variants

R. Strong, M. Holmes, D. Geraghty, 2003, The Journal of Biological Chemistry.

HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.

D. Goodlett, D. Geraghty, H. Marquardt, 1998, Journal of immunology.

Interactions between NKG2x Immunoreceptors and HLA-E Ligands Display Overlapping Affinities and Thermodynamics1

Roland K. Strong, R. Strong, D. Geraghty, 2005, The Journal of Immunology.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition

Allan C. deCamp, Jerome H. Kim, S. Zolla-Pazner, 2015, Science Translational Medicine.

The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes

L. Zhao, T. Lybrand, Å. Lernmark, 2021, EBioMedicine.

What is the MHC?

D. Geraghty, S. Powis, 1995, Immunology today.

High‐resolution genotyping of HLA class I loci in children with type 1 diabetes and celiac disease

D. Geraghty, D. Agardh, S. Alshiekh, 2021, HLA.

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy

Marlena Maziarz, Lue Ping Zhao, L. Zhao, 2019, PloS one.

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes

L. Zhao, Å. Lernmark, I. Kockum, 2016, Diabetes.

Genetic Association of the Antiviral Restriction Factor TRIM5α with Human Immunodeficiency Virus Type 1 Infection

L. Zhao, M. McElrath, D. Geraghty, 2006, Journal of Virology.

Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.

Alison A Motsinger, Marylyn D Ritchie, Richard T D'Aquila, 2006, The Journal of infectious diseases.

Nomenclature for factors of the HLA system, 2002.

W R Mayr, S G E Marsh, D E Geraghty, 2002, Tissue antigens.

HLA Class I Signal Sequences Certainof TAP-Dependent Peptides Derived from HLA-E Surface Expression Depends on Binding

D. Goodlett, D. Geraghty, H. Marquardt, 1998 .

NEW GENES IN THE HLA REGION

D. Geraghty, T. Guillaudeux, M. Janer, 1996 .

Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data.

D. Geraghty, C. Gassner, K. Hatake, 2002, Tissue antigens.

Nomenclature for Factors of the HLA System, 2004.

Effie W Petersdorf, Arne Svejgaard, Peter Parham, 2005, Human immunology.

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.

Allan C. deCamp, S. Hammer, J. Mascola, 2019, The Journal of clinical investigation.

CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants

Jerome H. Kim, J. Mullins, E. Sanders-Buell, 2014, PloS one.

sHLA-G and sHLA-I levels in follicular fluid are not associated with successful implantation.

Toshihiro Ito, D. Geraghty, H. Iwayama, 2016, Journal of reproductive immunology.

Soluble HLA-G isoforms: technical deficiencies lead to misinterpretations.

D. Geraghty, J. S. Hunt, 2005, Molecular human reproduction.

Cloning and nucleotide sequence of the trxA gene of Escherichia coli K-12

D. Geraghty, C. Lim, J. Fuchs, 1985, Journal of bacteriology.

Cloning andNucleotide Sequence ofthetrxAGeneof Escherichia coli K-12

D. Geraghty, 1985 .

NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.

A. Angulo, A. Muntasell, M. López-Botet, 2011, Blood.

Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient.

K. Tadokoro, K. Tokunaga, T. Inoue, 1999, Tissue antigens.

Down-Regulate Trophoblast Class I Human Cytomegalovirus Gene Products US 3

D. Geraghty, Eunok Kim, K. Ahn, 1999 .

Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity.

Asha B. Pillai, G. Neale, K. Nichols, 2020, Cytotherapy.

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults

B. Korber, B. Haynes, D. Montefiori, 2023, The Journal of clinical investigation.

FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells

Xinxia Peng, M. Katze, P. Gilbert, 2016, PloS one.

Nomenclature for factors of the HLA system, 2004.

W. Bodmer, P. Parham, J. Trowsdale, 2005, International Journal of Immunogenetics.

Nomenclature for factors of the HLA system, 2002.

W. Bodmer, P. Parham, B. Mach, 2002, European journal of immunogenetics.

Nomenclature for factors of the HLA system, update July

R. Blasczyk, D. Geraghty, C. Hurley, 2006 .

The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments.

D E Geraghty, H. Orr, B. Koller, 1992, Journal of immunology.

Canine DLA-79 gene: an improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host disease.

R. Storb, B. Storer, D. Geraghty, 2013, Tissue antigens.

RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules.

D. Geraghty, G. Gaudernack, N. Lee, 1995, Tissue antigens.

The telomeric and centromeric ends of HLA class I: MCD maps of YAC derived cosmids and sequence analysis of 740 kb of genomic DNA.

D. Geraghty, T. Guillaudeux, M. Janer, 1996, DNA sequence : the journal of DNA sequencing and mapping.

Sequence analysis and comparison of cDNAs of the zein multigene family .

J. Messing, D. Geraghty, I. Rubenstein, 1982, The EMBO journal.

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy

Lindsay N. Carpp, L. Zhao, T. Lybrand, 2021, Viruses.

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (2020/01 – 2021/03) Using a Statistical Learning Strategy

Lindsay N. Carpp, L. Zhao, T. Lybrand, 2021, bioRxiv.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, H. Liao, 2014, The Journal of clinical investigation.

Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

L. Zhao, T. Lybrand, D. Geraghty, 2022, Scientific Reports.

THE EXPRESSION OF HLA-G ANTIGEN IN DIFFERENT HUMAN TISSUES AND PLACENTAS AT DIFFERENT STAGES OF PREGNANCY

D. Geraghty, A. Ishitani, N. Ito, 1994 .

Mapping HLA for single nucleotide polymorphisms.

C. Jasoni, D. Geraghty, M. Janer, 1999, Reviews in immunogenetics.

Using Haplotype-Based Artificial Intelligence to Evaluate SARS-CoV-2 Novel Variants and Mutations

L. Zhao, T. Lybrand, D. Geraghty, 2023, JAMA network open.

Data acquisition, data storage, and data presentation in a modern genetics laboratory.

D E Geraghty, S Fortelny, B Guthrie, 2000, Reviews in immunogenetics.

Comparison of sequence‐specific oligonucleotide probe vs next generation sequencing for HLA‐A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single‐pass high‐resolution HLA typing in support of solid organ and hematopoietic cell transplant programs

A. Jaramillo, Anajane G. Smith, D. Geraghty, 2019, HLA.

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

Allan C. deCamp, R. Koup, Greg Finak, 2023, Science Translational Medicine.

Ethnic Variation of TET2 SNP rs2454206 and Association with Clinical Outcome in Childhood AML: A Report from the Children’s Oncology Group

S. Raimondi, E. Gamazon, A. Konkashbaev, 2015, Leukemia.

Peripheral Blood Mononuclear Cells from Women with Recurrent Abortion Exhibit an Aberrant Reaction to Release Cytokines upon the Direct Contact of Human Leukocyte Antigen‐G‐Expressing Cells

S. Kōzuma, Y. Taketani, D. Geraghty, 1998, American journal of reproductive immunology.

Quantitative Assessment of Human Leukocyte Antigen‐G Protein in Amniotic Fluid by a Double‐Determinant Enzyme‐Linked Immunosorbent Assay Using Anti‐Human Leukocyte Antigen‐G‐Specific Antibody ‘87G’

S. Kōzuma, Y. Taketani, O. Tsutsumi, 1999, American journal of reproductive immunology.

KIR genotype and haplotype repertoire in Kuwaiti healthy donors, hematopoietic cell transplant recipients and healthy family members

D. Geraghty, C. Pyo, M. Askar, 2023, HLA.

13th IHWS NK/KIR Joint Report. Killer immunoglobulin-like receptor genotypes, haplotypes and haplotype segregation patterns evaluated in the workshop KIR reference DNA panel.

M. Carrington, F. Christiansen, C. Witt, 2006 .

An Ultrasensitive Next Generation Sequencing Method for the Detection of Minimal Residual Disease and the Assessment of Chimerism Following Hematopoietic Cell Transplantation

Anajane G. Smith, D. Geraghty, S. Pereira, 2019, Biology of Blood and Marrow Transplantation.

Resequencing of the human major histocompatibility complex in patients with rheumatoid arthritis and healthy controls in Alaska Natives of Southeast Alaska.

L. P. Zhao, D. Geraghty, J. Hansen, 2007, Tissue antigens.

FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.

James Y. Dai, Jerome H. Kim, B. Haynes, 2014, The Journal of clinical investigation.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

C. Le, P. Parham, Jeffrey S. Miller, 2010, Blood.

The essential detail: the genetics and genomics of the primate immune response.

D. Geraghty, Q. Vu, C. Pyo, 2013, ILAR journal.

CHROMOSOMAL ORGANIZATION OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I GENE FAMILY By BEVERLY H . KOLLER, DANIEL E . GERAGHTY, ROBERT DEMARS,*

H. Orr, S. Rich, B. Koller, 2003 .

Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

M. Carrington, C. Witt, P. Parham, 2003, Tissue antigens.